Polpharma Looks To Supercharge Biosimilar Development With Help Of Chime

China-Based CDMO Chime Biologics Brings ‘Optimized Cost-Benefit Ratio’

 
• By Dean Rudge
  
Agreement business handshake partnership deal as a solution strategy with a team coming together out of tangled twisted roads on to a bridge to find a common goal.
Source: Shutterstock

More from Biosimilars

More from Business